Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
AIDS and Behavior
Erschienen in: AIDS and Behavior 7/2019

15.12.2018 | Original Paper

Applying the Information–Motivation–Behavioral Skills Model to Understand PrEP Intentions and Use Among Men Who Have Sex with Men

verfasst von: Jennifer L. Walsh

Erschienen in: AIDS and Behavior | Ausgabe 7/2019

Einloggen, um Zugang zu erhalten

Abstract

Research is needed to determine targets for interventions to increase pre-exposure prophylaxis (PrEP) uptake. The Information–Motivation–Behavioral Skills (IMB) model has not been tested for PrEP use among men who have sex with men (MSM). Men and transgender women and men were surveyed at a community event in the Midwest in 2016 (N = 476, 60% White, Mage = 35). New measures assessed PrEP knowledge, attitudes, stigma, descriptive and subjective norms, and intentions, and participants reported on PrEP use. We tested the IMB model for a subsample of HIV-negative MSM and transgender individuals (N = 357) using structural equation modeling. Only 12% of participants used PrEP. New measures performed well and were reliable (αs = 0.83–0.94). Structural models generally supported the IMB model: knowledge, stigma, and self-efficacy were directly associated with use, and attitudes, stigma, and descriptive norms had indirect effects on use via self-efficacy. The IMB model may be useful when developing PrEP interventions for MSM.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Prejean J, Song R, Hernandez A, Ziebell R, Green T, Walker F, et al. Estimated HIV incidence in the United States, 2006–2009. PLoS ONE. 2011;6(8):e17502.CrossRefPubMedPubMedCentral
2.
Centers for Disease Control and Prevention. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United States and 6 US dependent areas—2010. HIV Surveill. 2012;17:3.
3.
Thigpen MC, Kebaabetswe PM, Paxton LA, Smith DK, Rose CE, Segolodi TM, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012;367(5):423–34.CrossRefPubMed
4.
Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367(5):399–410.CrossRefPubMedPubMedCentral
5.
Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New Engl J Med. 2010;363(27):2587–99.CrossRefPubMed
6.
Molina J-M, Capitant C, Spire B, Pialoux G, Chidiac C, Charreau I: On demand PrEP with oral TDF-FTC in MSM: Results of the ANRS Ipergay trial. In: Conference on Retroviruses and Opportunistic Infections; Seattle, WA2015. pp. 23–26.
7.
McCormack S, Dunn DT, Desai M, Dolling DI, Gafos M, Gilson R, et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet. 2016;387(10013):53–60.CrossRefPubMedPubMedCentral
8.
Donnell D, Baeten JM, Bumpus NN, Brantley J, Bangsberg DR, Haberer JE, et al. HIV protective efficacy and correlates of tenofovir blood concentrations in a clinical trial of PrEP for HIV prevention. J Acquir Immune Defic Syndr. 2014;66(3):340–8.CrossRefPubMedPubMedCentral
9.
Anderson PL, Glidden DV, Liu A, Buchbinder S, Lama JR, Guanira JV, et al. Emtricitabine–tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med. 2012;4(151):151ra25.CrossRef
10.
Grant RM, Anderson PL, McMahan V, Liu A, Amico KR, Mehrotra M, et al. Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. Lancet Infect Dis. 2014;14(9):820–9.CrossRefPubMedPubMedCentral
11.
Laufer FN, O’Connell DA, Feldman I, Zucker HA. vital signs: increased medicaid prescriptions for preexposure prophylaxis against HIV infection—New York, 2012–2015. Morb Mortal Wkly Rep. 2015;64(46):1296–301.CrossRef
12.
Bush S, Ng L, Magnuson D, Piontkowsky D, Mera Giler R, editors. Significant uptake of Truvada for pre-exposure prophylaxis (PrEP) utilization in the US in late 2014–1Q 2015. In: IAPAC Treatment, Prevention, and Adherence Conference 2015.
13.
Scanlin K, Salcuni P, Edelstein Z, Daskalakis D, Mensah N, Tsoi B, et al. editors. Increasing PrEP use among Men Who Have Sex With Men, New York City 2013–2015. In: Conference on Retroviruses and opportunistic infections. 2016.
14.
Delaney K, Sanchez T, Bowles K, Oraka E, DiNenno E, Sullivan P, editors. Awareness and use of PrEP appear to be increasing among internet samples of US MSM. In: Conference on Retroviruses and Opportunistic Infections. 2016.
15.
Hood JE, Buskin SE, Dombrowski JC, Kern DA, Barash EA, Katzi DA, et al. Dramatic increase in preexposure prophylaxis use among MSM in Washington state. AIDS. 2016;30(3):515–9.PubMed
16.
Grant R, Liu A, Hecht J, Buchbinder S, Weber S, Crouch P: Scale-up of preesposure prophylaxis in San Francisco to impact HIV incidence. In: Conference on Retroviruses and Opportunistic Infections; Seattle, WA; 2015.
17.
Smith DK, Van Handel M, Wolitski RJ, Stryker JE, Hall HI, Prejean J, et al. Vital signs: estimated percentages and numbers of adults with indications for preexposure prophylaxis to prevent HIV acquisition—United States, 2015. MMWR. 2015;64(46):1291–5.PubMed
18.
Siegler AJ, Mouhanna F, Giler RM, McCallister S, Yeung H, Jones J, et al: Distribution of active PrEP prescriptions and the PrEP-to-need ratio, US, Q2 2017. In: 25th Conference on Retroviruses and Opportunistic Infections (CROI 2018); Boston; 2018.
19.
20.
Fisher JD, Fisher WA, Shuper PA. The information–motivation–behavioral skills model of HIV preventive behavior. Emerg Theor Health Prom Pract Res. 2009;2:21–64.
21.
Johnson BT, Redding CA, DiClemente RJ, Mustanski BS, Dodge B, Sheeran P, et al. A network-individual-resource model for HIV prevention. AIDS Behav. 2010;14(Suppl 2):204–21.CrossRefPubMedPubMedCentral
22.
Fisher JD, Fisher WA, Amico KR, Harman JJ. An information–motivation–behavioral skills model of adherence to antiretroviral therapy. Health Psychol. 2006;25(4):462–73.CrossRefPubMed
23.
Fisher WA, Fisher JD, Harman J. The Information-Motivation-Behavioral Skills Model: A general social psychological approach to understanding and promoting health behavior. Social Psychological Foundations of Health and Illness. Hoboken: Blackwell Publishing Ltd.; 2009. p. 82–106.
24.
Fisher WA, Fisher JD, Harman J. The information–motivation–behavioral skills model: a general social psychological approach to understanding and promoting health behavior. Soc Psychol Found Health Illness. 2003;40:82–106.CrossRef
25.
Dubov A, Altice FL, Fraenkel L. An information–motivation–behavioral skills model of PrEP uptake. AIDS Behav. 2018;22:3603–16.CrossRefPubMed
26.
Krakower DS, Mimiaga MJ, Rosenberger JG, Novak DS, Mitty JA, White JM, et al. Limited awareness and low immediate uptake of pre-exposure prophylaxis among men who have sex with men using an internet social networking site. PLoS ONE. 2012;7(3):e33119.CrossRefPubMedPubMedCentral
27.
Garnett M, Hirsch-Moverman Y, Franks J, Hayes-Larson E, El-Sadr WM, Mannheimer S. Limited awareness of pre-exposure prophylaxis among black men who have sex with men and transgender women in New York city. AIDS Care. 2018;30(1):9–17.CrossRefPubMed
28.
Bauermeister JA, Meanley S, Pingel E, Soler JH, Harper GW. PrEP awareness and perceived barriers among single young men who have sex with men. Curr HIV Res. 2013;11(7):520–7.CrossRefPubMedPubMedCentral
29.
Goedel WC, Halkitis PN, Greene RE, Duncan DT. Correlates of awareness of and willingness to use pre-exposure prophylaxis (PrEP) in gay, bisexual, and other men who have sex with men who use geosocial-networking smartphone applications in New York City. AIDS Behav. 2016;20(7):1435–42.CrossRefPubMed
30.
Dolezal C, Frasca T, Giguere R, Ibitoye M, Cranston RD, Febo I, et al. Awareness of post-exposure prophylaxis (PEP) and pre-exposure prophylaxis (PrEP) is low but interest is high among men engaging in condomless anal sex with men in Boston, Pittsburgh, and San Juan. AIDS Educ Prev. 2015;27(4):289–97.CrossRefPubMedPubMedCentral
31.
Eaton LA, Driffin DD, Bauermeister J, Smith H, Conway-Washington C. Minimal awareness and stalled uptake of pre-exposure prophylaxis (PrEP) among at risk, HIV-negative, black men who have sex with men. AIDS Pat Care STDs. 2015;29(8):423–9.CrossRef
32.
Mosley T, Khaketla M, Armstrong HL, Cui Z, Sereda P, Lachowsky NJ, et al. Trends in awareness and use of HIV PrEP among gay, bisexual, and other men who have sex with men in Vancouver, Canada 2012–2016. AIDS Behav. 2018;22:3550–65.CrossRefPubMed
33.
Krotchko J, editor. Changes in Awareness of Human Immunodeficiency Virus (HIV) Pre-exposure Prophylaxis (PrEP) in High-Risk Populations of Men Who Have Sex With Men (MSM) in Denver Colorado in 2008, 2011, and 2014: Implications for Implementation. Open Forum Infectious Diseases. Oxford: Oxford University Press; 2016.
34.
35.
Salcuni P, Smolen J, Jain S, Myers J, Edelstein Z. Trends and associations with PrEP prescription among 602 New York City (NYC) ambulatory care practices, 2014–2016. Open Forum Infect Dis. 2017;4(Suppl 1):S21.CrossRefPubMedCentral
36.
Shrestha R, Altice FL, Huedo-Medina TB, Karki P, Copenhaver M. Willingness to use pre-exposure prophylaxis (PrEP): an empirical test of the information–motivation–behavioral skills (IMB) model among high-risk drug users in treatment. AIDS Behav. 2017;21(5):1299–308.CrossRefPubMedPubMedCentral
37.
King HL, Keller SB, Giancola MA, Rodriguez DA, Chau JJ, Young JA, et al. Pre-exposure prophylaxis accessibility research and evaluation (PrEPARE Study). AIDS Behav. 2014;18(9):1722–5.CrossRefPubMedPubMedCentral
38.
Liu A, Cohen S, Follansbee S, Cohan D, Weber S, Sachdev D, et al. Early experiences implementing pre-exposure prophylaxis (PrEP) for HIV prevention in San Francisco. PLoS Med. 2014;11(3):e1001613.CrossRefPubMedPubMedCentral
39.
Biello KB, Oldenburg CE, Mitty JA, Closson EF, Mayer KH, Safren SA, et al. The “Safe Sex” conundrum: anticipated stigma from sexual partners as a barrier to PrEP use among substance using MSM engaging in transactional sex. AIDS Behav. 2017;21(1):300–6.CrossRefPubMedPubMedCentral
40.
Oldenburg CE, Mitty JA, Biello KB, Closson EF, Safren SA, Mayer KH, et al. Differences in attitudes about HIV pre-exposure prophylaxis use among stimulant versus alcohol using men who have sex with men. AIDS Behav. 2016;20(7):1451–60.CrossRefPubMedPubMedCentral
41.
Oldenburg CE, Perez-Brumer AG, Hatzenbuehler M, Krakower DS, Novak DS, Mimiaga MJ, et al. Structural stigma affects access to pre- and post- exposure prophylaxis and HIV risk among men who have sex with men (MSM) in the United States; 2014.
42.
Perez-Figueroa RE, Kapadia F, Barton SC, Eddy JA, Halkitis PN. Acceptability of PrEP uptake among racially/ethnically diverse young men who have sex with men: the P18 study. AIDS Educ Prev. 2015;27(2):112–25.CrossRefPubMedPubMedCentral
43.
Garcia J, Parker C, Parker RG, Wilson PA, Philbin M, Hirsch JS. Psychosocial implications of homophobia and HIV stigma in social support networks: insights for high-impact HIV prevention among Black men who have sex with men. Health Educ Behav. 2016;43(2):217–25.CrossRefPubMed
44.
Van der Elst EM, Mbogua J, Operario D, Mutua G, Kuo C, Mugo P, et al. High acceptability of HIV pre-exposure prophylaxis but challenges in adherence and use: qualitative insights from a phase I trial of intermittent and daily PrEP in at-risk populations in Kenya. AIDS Behav. 2013;17(6):2162–72.CrossRefPubMedPubMedCentral
45.
Philbin MM, Parker CM, Parker RG, Wilson PA, Garcia J, Hirsch JS. The promise of pre-exposure prophylaxis for Black men who have sex with men: an ecological approach to attitudes, beliefs, and barriers. AIDS Patient Care STDS. 2016;30(6):282–90.CrossRefPubMedPubMedCentral
46.
Zarwell M, Payne N, Robinson W, editors. Usage and perceptions of PrEP among men who have sex with men (MSM) in New Orleans, 2014. In: 143rd APHA Annual Meeting and Exposition, Chicago, IL; 2015.
47.
Mantell JE, Sandfort TG, Hoffman S, Guidry JA, Masvawure TB, Cahill S. Knowledge and attitudes about pre-exposure prophylaxis (PrEP) among sexually active men who have sex with men (MSM) participating in New York City Gay Pride events. LGBT Health. 2014;1(2):93–7.CrossRefPubMedPubMedCentral
48.
Koechlin FM, Fonner VA, Dalglish SL, O’Reilly KR, Baggaley R, Grant RM, et al. Values and preferences on the use of oral pre-exposure prophylaxis (PrEP) for HIV prevention among multiple populations: a systematic review of the literature. AIDS Behav. 2017;21(5):1325–35.CrossRefPubMed
49.
Smith DK, Toledo L, Smith DJ, Adams MA, Rothenberg R. Attitudes and program preferences of African-American urban young adults about pre-exposure prophylaxis (PrEP). AIDS Educ Prev. 2012;24(5):408–21.CrossRefPubMed
50.
Galindo GR, Walker JJ, Hazelton P, Lane T, Steward WT, Morin SF, et al. Community member perspectives from transgender women and men who have sex with men on pre-exposure prophylaxis as an HIV prevention strategy: implications for implementation. Implement Sci. 2012;7:116.CrossRefPubMedPubMedCentral
51.
Brooks RA, Landovitz RJ, Regan R, Lee SJ, Allen VC Jr. Perceptions of and intentions to adopt HIV pre-exposure prophylaxis among black men who have sex with men in Los Angeles. Int J STD AIDS. 2015;26(14):1040–8.CrossRefPubMedPubMedCentral
52.
Golub SA, Gamarel KE, Rendina HJ, Surace A, Lelutiu-Weinberger CL. From efficacy to effectiveness: facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in New York City. AIDS Patient Care STDs. 2013;27(4):248–54.CrossRefPubMedPubMedCentral
53.
Carey MP, Morrison-Beedy D, Johnson BT. The HIV-Knowledge Questionnaire: development and evaluation of a reliable, valid, and practical self-administered questionnaire. AIDS Behav. 1997;1(1):61–74.CrossRef
54.
Helweg-Larsen M, Collins BE. The UCLA Multidimensional Condom Attitudes Scale: documenting the complex determinants of condom use in college students. Health Psychol. 1994;13(3):224–37.CrossRefPubMed
55.
Fisher TD, Davis CM, Yarber WL, Davis SL. Handbook of sexuality-related measures. London: Routledge; 2013.
56.
Brown IS. Development of a scale to measure attitude toward the condom as a method of birth control. J Sex Res. 1984;20(3):255–63.CrossRef
57.
St Lawrence JS, Reitman D, Jefferson KW, Alleyne E, Brasfield TL, Shirley A. Factor structure and validation of an adolescent version of the Condom Attitude Scale: an instrument for measuring adolescents’ attitudes toward condoms. Psychol Assess. 1994;6(4):352.CrossRef
58.
Donenberg GR, Schwartz RM, Emerson E, Wilson HW, Bryant FB, Coleman G. Applying a cognitive-behavioral model of HIV risk to youths in psychiatric care. AIDS Educ Prev. 2005;17(3):200–16.CrossRefPubMedPubMedCentral
59.
Carey MP, Braaten LS, Maisto SA, Gleason JR, Forsyth AD, Durant LE, et al. Using information, motivational enhancement, and skills training to reduce the risk of HIV infection for low-income urban women: a second randomized clinical trial. Health Psychol. 2000;19(1):3–11.CrossRefPubMed
60.
O’Leary A, Jemmott LS, Jemmott JB. Mediation analysis of an effective sexual risk-reduction intervention for women: the importance of self-efficacy. Health Psychol. 2008;27(2s):S180–4.CrossRefPubMed
61.
Carey MP, Senn TE, Walsh JL, Coury-Doniger P, Urban MA, Fortune T, et al. Evaluating a brief, video-based sexual risk reduction intervention and assessment reactivity with STI clinic patients: results from a randomized controlled trial. AIDS Behav. 2015;19(7):1228–46.CrossRefPubMedPubMedCentral
62.
Rocca CH, Harper CC. Do racial and ethnic differences in contraceptive attitudes and knowledge explain disparities in method use? Persp Sex Reprod Health. 2012;44(3):150–8.CrossRef
63.
Graham JW, Taylor BJ, Olchowski AE, Cumsille PE. Planned missing data designs in psychological research. Psychol Methods. 2006;11(4):323–43.CrossRefPubMed
64.
65.
Clark LA, Watson D. Constructing validity: basic issues in objective scale development. Psychol Assess. 1995;7(3):309.CrossRef
66.
Kline RB. Principles and practice of structural equation modeling. New York: Guilford Press; 2011.
67.
Hu L, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis. Conventional criteria versus new alternatives. Struct Equ Modeling. 1999;6(1):1–55.CrossRef
68.
Zedeck S. APA dictionary of statistics and research methods. Washington, DC: American Psychological Association; 2014.CrossRef
69.
Bauer DJ. A more general model for testing measurement invariance and differential item functioning. Psychol Methods. 2017;22(3):507–26.CrossRefPubMed
70.
Little TD, Cunningham WA, Shahar G, Widaman KF. To parcel or not to parcel: exploring the question, weighing the merits. Struct Equ Modeling. 2002;9(2):151–73.CrossRef
71.
Muthén LK, Muthén BO. Mplus user’s guide. Los Angeles: Muthén & Muthén; 1998.
72.
73.
Hoots BE, Finlayson T, Nerlander L, Paz-Bailey G. Willingness to take, use of, and indications for pre-exposure prophylaxis among men who have sex with Men-20 US Cities, 2014. Clin Infect Dis. 2016;63(5):672–7.CrossRefPubMedPubMedCentral
74.
Mera R, McCallister S, Palmer B, Mayer G, Magnuson D, Rawlings M. FTC/TDF (Truvada) for HIV pre-exposure prophylaxis (PrEP) utilization in the United States: 2012–2015. Foster City, CA, USA. 2016.
75.
Fisher JD, Fisher WA, Williams SS, Malloy TE. Empirical tests of an information-motivation-behavioral skills model of AIDS-preventive behavior with gay men and heterosexual university students. Health Psychol. 1994;13(3):238.CrossRefPubMed
76.
Kalichman SC, Picciano JF, Roffman RA. Motivation to reduce HIV risk behaviors in the context of the information, motivation and behavioral skills (IMB) model of HIV prevention. J Health Psychol. 2008;13(5):680–9.CrossRefPubMed
77.
Mustanski B, Donenberg G, Emerson E. I can use a condom, I just don’t: the importance of motivation to prevent HIV in adolescent seeking psychiatric care. AIDS Behav. 2006;10(6):753–62.CrossRefPubMed
78.
Robertson AA, Stein JA, Baird-Thomas C. Gender differences in the prediction of condom use among incarcerated juvenile offenders: testing the information-motivation-behavior skills (IMB) model. J Adoles Health. 2006;38(1):18–25.CrossRef
79.
Walsh JL, Senn TE, Scott-Sheldon LA, Vanable PA, Carey MP. Predicting condom use using the Information-Motivation-Behavioral Skills (IMB) model: a multivariate latent growth curve analysis. Ann Behav Med. 2011;42(2):235.CrossRefPubMedPubMedCentral
80.
Petroll AE, Walsh JL, Owczarzak JL, McAuliffe TL, Bogart LM, Kelly JA. PrEP awareness, familiarity, comfort, and prescribing experience among US primary care providers and HIV specialists. AIDS Behav. 2017;21(5):1256–67.CrossRefPubMedPubMedCentral
81.
Raifman JR, Flynn C, German D. Healthcare provider contact and pre-exposure prophylaxis in Baltimore men who have sex with men. Am J Prev Med. 2017;52(1):55–63.CrossRefPubMed
82.
Pulsipher C, Montoya J, Plant A, Curtis P, Holloway I, Leibowitz A. Addressing PrEP disparities among young gay and bisexual men in California. California: California HIV/AIDS Policy Research Centers; 2016.
83.
Bogorodskaya M, Avery A. Favorable attitudes but low awareness and restricted access to pre-exposure prophylaxis (PrEP) against human immunodeficiency virus (HIV) in an urban midwestern community. Open Forum Infectious Dis. 2016;3:506.CrossRef
84.
Sheeran P, Abraham C, Orbell S. Psychosocial correlates of heterosexual condom use: a meta-analysis. Psychol Bull. 1999;125(1):90–132.CrossRefPubMed
85.
Kalichman SC, Simbayi LC. HIV testing attitudes, AIDS stigma, and voluntary HIV counselling and testing in a black township in Cape Town, South Africa. Sex Trans Infect. 2003;79(6):442–7.CrossRef
86.
Fortenberry JD, McFarlane M, Bleakley A, Bull S, Fishbein M, Grimley DM, et al. Relationships of stigma and shame to gonorrhea and HIV screening. Am J Public Health. 2002;92(3):378–81.CrossRefPubMedPubMedCentral
87.
Kellerman SE, Lehman JS, Lansky A, Stevens MR, Hecht FM, Bindman AB, et al. HIV testing within at-risk populations in the United States and the reasons for seeking or avoiding HIV testing. J Acquir Immune Defic Syndr. 2002;31(2):202–10.CrossRefPubMed
88.
Amico KR, Toro-Alfonso J, Fisher JD. An empirical test of the information, motivation and behavioral skills model of antiretroviral therapy adherence. AIDS Care. 2005;17(6):661–73.CrossRefPubMed
89.
Starace F, Massa A, Amico KR, Fisher JD. Adherence to antiretroviral therapy: an empirical test of the information-motivation-behavioral skills model. Health Psychol. 2006;25(2):153–62.CrossRefPubMed
90.
Calabrese SK, Underhill K. How stigma surrounding the use of HIV preexposure prophylaxis undermines prevention and pleasure: a call to destigmatize “truvada whores”. Am J public Health. 2015;105(10):1960–4.CrossRefPubMedPubMedCentral
91.
92.
Strauss BB, Greene GJ, Phillips G 2nd, Bhatia R, Madkins K, Parsons JT, et al. Exploring patterns of awareness and use of HIV pre-exposure prophylaxis among young men who have sex with men. AIDS Behav. 2016;21(5):1288–98.CrossRef
93.
Chan PA, Mena L, Patel R, Oldenburg CE, Beauchamps L, Perez-Brumer AG, et al. Retention in care outcomes for HIV pre-exposure prophylaxis implementation programmes among men who have sex with men in three US cities. J Int AIDS Soc. 2016;19(1):20903.CrossRefPubMedPubMedCentral
94.
Underhill K, Morrow KM, Colleran CM, Holcomb R, Operario D, Calabrese SK, et al. Access to healthcare, HIV/STI testing, and preferred pre-exposure prophylaxis providers among men who have sex with men and men who engage in street-based sex work in the US. PLoS ONE. 2014;9(11):e112425.CrossRefPubMedPubMedCentral
95.
Maloney KM, Krakower DS, Ziobro D, Rosenberger JG, Novak D, Mayer KH. Culturally competent sexual healthcare as a prerequisite for obtaining preexposure prophylaxis: findings from a qualitative study. LGBT Health. 2017;4(4):310–4.CrossRefPubMedPubMedCentral
96.
Eaton LA, Driffin DD, Smith H, Conway-Washington C, White D, Cherry C. Psychosocial factors related to willingness to use pre-exposure prophylaxis for HIV prevention among Black men who have sex with men attending a community event. Sex Health. 2014;11(3):244–51.CrossRefPubMedPubMedCentral
97.
Krakower D, Oldenburg C, Mimiaga M, Novak D, Rosenberger J, Elsesser S, et al., editors. Patient-provider communication about sexual behaviors and preexposure prophylaxis: results from a national online survey of men who have sex with men in the United States. Poster presented at the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment & Prevention, Vancouver, British Columbia, Canada; 2015.
98.
Berendes S, Rimal RN. Addressing the slow uptake of HIV testing in Malawi: the role of stigma, self-efficacy, and knowledge in the Malawi BRIDGE Project. J Assoc Nurses AIDS Care. 2011;22(3):215–28.CrossRefPubMed
99.
Gifford AL, Bormann JE, Shively MJ, Wright BC, Richman DD, Bozzette SA. Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. J Acquir Immune Defic Syndr. 2000;23(5):386–95.CrossRefPubMed
100.
Barclay TR, Hinkin CH, Castellon SA, Mason KI, Reinhard MJ, Marion SD, et al. Age-associated predictors of medication adherence in HIV-positive adults: health beliefs, self-efficacy, and neurocognitive status. Health Psychol. 2007;26(1):40–9.CrossRefPubMedPubMedCentral
Metadaten
Titel
Applying the Information–Motivation–Behavioral Skills Model to Understand PrEP Intentions and Use Among Men Who Have Sex with Men
verfasst von
Jennifer L. Walsh
Publikationsdatum
15.12.2018
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 7/2019
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-018-2371-3

Weitere Artikel der Ausgabe 7/2019

AIDS and Behavior 7/2019 Zur Ausgabe

Original Paper

“A Gay Man and a Doctor are Just like, a Recipe for Destruction”: How Racism and Homonegativity in Healthcare Settings Influence PrEP Uptake Among Young Black MSM

Original Paper

Network Modeling of PrEP Uptake on Referral Networks and Health Venue Utilization Among Young Men Who Have Sex with Men

Original Paper

PrEP in the Real World: Predictors of 6-Month Retention in a Diverse Urban Cohort

Original Paper

Disclosure of HIV Serostatus and Pre-exposure Prophylaxis Use on Internet Hookup Sites Among Men Who have Sex with Men

Original Paper

Awareness and Perceived Effectiveness of HIV Treatment as Prevention Among Men Who Have Sex with Men in New York City

Original Paper

Pre-exposure Prophylaxis (PrEP) Awareness and Use Within High HIV Transmission Networks

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 | Hypertonie | Nachrichten

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 | Parkinson-Krankheit | Nachrichten

Viel Bewegung in der Parkinsonforschung

25.04.2024 | Nierenkarzinom | Nachrichten

Adjuvante Immuntherapie verlängert Leben bei RCC
weitere anzeigen

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise